Wake Forest University Baptist Medical Center
Researchers disprove long-standing belief about HIV treatment
Published in Hepatitis Weekly, August 11th, 2008
Hepatitis C (HCV) infection is more serious in HIV-infected people, leading to rapid liver damage, according to the Centers for Disease Control. Intravenous drug use is a main method of contraction for both HIV and HCV and 50 to 90 percent of HIV-infected drug users are also infected with HCV.
The Wake Forest Baptist study looked at whether having HCV co-infection impairs...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2008-08-11)
More Articles from Hepatitis Weekly
- Imperial College London
Liver damage in hepatitis C patients could be treated with warfarin, says study - Acute Hepatitis
New acute hepatitis research from Okayama University, Medical Department discussed - Alcoholism
Reports summarize alcoholism research from S.J. Thomson and co-authors - Hepatitis
New data from V. Verma et al illuminate research in hepatitis - Hepatitis A Virus
Findings from S. Sellamuthu and co-authors broaden understanding of hepatitis A virus - Hepatitis B Virus
New hepatitis B virus research from T.T.T. Huy et al outlined - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
